Related Experiment Video
Updated: Oct 22, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Heterogeneity in COVID-19 Patients at Multiple Levels of Granularity: From Biclusters to Clinical Interventions
Suresh K Bhavnani1,2, Erich Kummerfeld3, Weibin Zhang1
1Preventive Medicine and Population Health.
Insights
COVID-19 patients with pre-existing conditions face worse outcomes. This study uses network analysis to identify distinct patient subgroups based on co-occurring comorbidities, enabling more targeted clinical care strategies.
Area of Science:
- Medical Informatics
- Network Science
- Epidemiology
Background:
- COVID-19 disproportionately affects older adults and minorities with comorbidities.
- Significant heterogeneity exists in comorbidity profiles, yet patterns of co-occurrence are poorly understood.
- Understanding comorbidity patterns is crucial for developing targeted COVID-19 care strategies.
Purpose of the Study:
- To quantitatively and visually analyze heterogeneity in comorbidity profiles among COVID-19 inpatients.
- To identify distinct patient subgroups based on co-occurring comorbidities.
- To inform the design of targeted clinical interventions for COVID-19 patients.
Main Methods:
- Utilized bipartite networks to analyze comorbidity data from electronic health records.
- Examined data from 12 hospitals and 60 clinics in the Minneapolis region.
- Employed a multigranular approach to analyze heterogeneity at cohort, subgroup, and patient levels.
Main Results:
- Successfully visualized and quantified heterogeneity in COVID-19 patient comorbidity profiles.
- Identified distinct patient subgroups based on co-occurring conditions.
- Demonstrated a framework for rapid translation of findings into clinical interventions.
Conclusions:
- Bipartite network analysis effectively reveals complex comorbidity patterns in COVID-19 patients.
- The multigranular framework facilitates targeted clinical care design.
- This approach can be extended to analyze other biomedical phenomena for accelerated clinical translation.
Abstract:
Several studies have shown that COVID-19 patients with prior comorbidities have a higher risk for adverse outcomes, resulting in a disproportionate impact on older adults and minorities that fit that profile. However, although there is considerable heterogeneity in the comorbidity profiles of these populations, not much is known about how prior comorbidities co-occur to form COVID-19 patient subgroups, and their implications for targeted care. Here we used bipartite networks to quantitatively and visually analyze heterogeneity in the comorbidity profiles of COVID-19 inpatients, based on electronic health records from 12 hospitals and 60 clinics in the greater Minneapolis region. This approach enabled the analysis and interpretation of heterogeneity at three levels of granularity (cohort, subgroup, and patient), each of which enabled clinicians to rapidly translate the results into the design of clinical interventions. We discuss future extensions of the multigranular heterogeneity framework, and conclude by exploring how the framework could be used to analyze other biomedical phenomena including symptom clusters and molecular phenotypes, with the goal of accelerating translation to targeted clinical care.
Related Concept Videos
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
Biostatistics: Overview
Discrete variables are...
Steps in Outbreak Investigation
Causality in Epidemiology
Bias in Epidemiological Studies
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...

